Published in Proc Natl Acad Sci U S A on February 01, 1988
Rotavirus gene structure and function. Microbiol Rev (1989) 6.95
Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol (1988) 3.20
Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4. Proc Natl Acad Sci U S A (1990) 2.90
Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J Cell Biol (1990) 2.83
Nucleotide sequence of VP4 and VP7 genes of human rotaviruses with subgroup I specificity and long RNA pattern: implication for new G serotype specificity. J Virol (1990) 2.42
The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J (2002) 2.41
Mutagenesis of the putative fusion domain of the Semliki Forest virus spike protein. J Virol (1991) 2.30
Cholesterol is required for infection by Semliki Forest virus. J Cell Biol (1991) 2.24
Detection and characterization of novel rotavirus strains in the United States. J Clin Microbiol (1998) 2.16
Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11. J Virol (1988) 2.08
Structural rearrangements in the membrane penetration protein of a non-enveloped virus. Nature (2004) 2.05
Three-dimensional structure of the rotavirus haemagglutinin VP4 by cryo-electron microscopy and difference map analysis. EMBO J (1994) 1.90
Rotavirus contains integrin ligand sequences and a disintegrin-like domain that are implicated in virus entry into cells. Proc Natl Acad Sci U S A (1997) 1.82
The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. J Virol (1989) 1.80
Atomic model of an infectious rotavirus particle. EMBO J (2010) 1.79
Integrins alpha2beta1 and alpha4beta1 can mediate SA11 rotavirus attachment and entry into cells. J Virol (2000) 1.72
Complete nucleotide sequence of the gene encoding VP4 of a human rotavirus (strain K8) which has unique VP4 neutralization epitopes. J Virol (1989) 1.71
Trypsin activation pathway of rotavirus infectivity. J Virol (1996) 1.63
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. J Clin Microbiol (1989) 1.58
Intraluminal proteolytic activation plays an important role in replication of type 1 reovirus in the intestines of neonatal mice. J Virol (1990) 1.56
Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope. J Virol (1992) 1.53
Rotavirus proteins VP7, NS28, and VP4 form oligomeric structures. J Virol (1990) 1.52
Binding to sialic acids is not an essential step for the entry of animal rotaviruses to epithelial cells in culture. J Virol (1993) 1.50
Serotype-specific epitope(s) present on the VP8 subunit of rotavirus VP4 protein. J Virol (1991) 1.47
Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies. J Clin Microbiol (1993) 1.46
Whole genome sequence and phylogenetic analyses reveal human rotavirus G3P[3] strains Ro1845 and HCR3A are examples of direct virion transmission of canine/feline rotaviruses to humans. Virology (2008) 1.43
Rotavirus capsid protein VP5* permeabilizes membranes. J Virol (1999) 1.42
Selective membrane permeabilization by the rotavirus VP5* protein is abrogated by mutations in an internal hydrophobic domain. J Virol (2000) 1.40
Comparative analysis of the VP3 gene of divergent strains of the rotaviruses simian SA11 and bovine Nebraska calf diarrhea virus. J Virol (1988) 1.39
Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge. J Virol (1990) 1.37
Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea. J Virol (1998) 1.37
Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure. J Virol (1994) 1.35
Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5* core. J Virol (2001) 1.33
Distribution of VP4 gene alleles in human rotaviruses by using probes to the hyperdivergent region of the VP4 gene. J Clin Microbiol (1993) 1.30
Cleavage of rhesus rotavirus VP4 after arginine 247 is essential for rotavirus-like particle-induced fusion from without. J Virol (1998) 1.27
Liposome-mediated transfection of intact viral particles reveals that plasma membrane penetration determines permissivity of tissue culture cells to rotavirus. J Clin Invest (1992) 1.24
Survey on the distribution of the gene 4 alleles of human rotaviruses by polymerase chain reaction. Epidemiol Infect (1994) 1.22
Interactions between the two surface proteins of rotavirus may alter the receptor-binding specificity of the virus. J Virol (1996) 1.22
Rotavirus spike protein VP4 is present at the plasma membrane and is associated with microtubules in infected cells. J Virol (2000) 1.22
The nucleotide sequence of the VP3 gene of porcine rotavirus OSU. Nucleic Acids Res (1988) 1.20
Assembly of highly infectious rotavirus particles recoated with recombinant outer capsid proteins. J Virol (2006) 1.20
DNA amplification-restricted transcription-translation: rapid analysis of rhesus rotavirus neutralization sites. Proc Natl Acad Sci U S A (1990) 1.20
Neutralization epitopes on rotavirus SA11 4fM outer capsid proteins. J Virol (1990) 1.20
Rotavirus interaction with isolated membrane vesicles. J Virol (1994) 1.18
High-resolution molecular and antigen structure of the VP8* core of a sialic acid-independent human rotavirus strain. J Virol (2006) 1.16
VP4 monotype specificities among porcine rotavirus strains of the same VP4 serotype. J Virol (1991) 1.16
The VP5 domain of VP4 can mediate attachment of rotaviruses to cells. J Virol (2000) 1.16
Serological characterization of bovine rotaviruses isolated from dairy and beef herds in Argentina. J Clin Microbiol (1989) 1.14
Comparative amino acid sequence analysis of VP4 for VP7 serotype 6 bovine rotavirus strains NCDV, B641, and UK. J Virol (1991) 1.11
A rotavirus spike protein conformational intermediate binds lipid bilayers. J Virol (2009) 1.10
Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice. J Clin Microbiol (1996) 1.10
Rotavirus-induced fusion from without in tissue culture cells. J Virol (1995) 1.10
Rotavirus YM gene 4: analysis of its deduced amino acid sequence and prediction of the secondary structure of the VP4 protein. J Virol (1991) 1.09
Interaction of rotaviruses with Hsc70 during cell entry is mediated by VP5. J Virol (2003) 1.08
Sequence analysis of gene 11 equivalents from "short" and "super short" strains of rotavirus. J Virol (1990) 1.08
Virus-like particle-induced fusion from without in tissue culture cells: role of outer-layer proteins VP4 and VP7. J Virol (1997) 1.07
Similarity of the outer capsid protein VP4 of the Gottfried strain of porcine rotavirus to that of asymptomatic human rotavirus strains. J Virol (1990) 1.07
Alternative intermolecular contacts underlie the rotavirus VP5* two- to three-fold rearrangement. EMBO J (2006) 1.06
Comparison of enzyme immunoassay, PCR, and type-specific cDNA probe techniques for identification of group A rotavirus gene 4 types (P types). J Clin Microbiol (1997) 1.04
Isolation of a human rotavirus strain with a super-short RNA pattern and a new P2 subtype. J Clin Microbiol (1999) 1.03
Rotavirus spike structure and polypeptide composition. J Virol (1991) 1.03
Intracellular manipulation of disulfide bond formation in rotavirus proteins during assembly. J Virol (1994) 1.02
Functional and structural analysis of the sialic acid-binding domain of rotaviruses. J Virol (1997) 1.02
pH-induced conformational change of the rotavirus VP4 spike: implications for cell entry and antibody neutralization. J Virol (2005) 0.99
Location of intrachain disulfide bonds in the VP5* and VP8* trypsin cleavage fragments of the rhesus rotavirus spike protein VP4. J Virol (1993) 0.99
Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus. J Virol (1990) 0.99
Characterization of recombinant polioviruses expressing regions of rotavirus VP4, hepatitis B surface antigen, and herpes simplex virus type 2 glycoprotein D. J Virol (1995) 0.98
Attachment and growth of human rotaviruses RV-3 and S12/85 in Caco-2 cells depend on VP4. J Virol (1998) 0.98
Carbohydrates facilitate correct disulfide bond formation and folding of rotavirus VP7. J Virol (1998) 0.96
Monkey rotavirus binding to alpha2beta1 integrin requires the alpha2 I domain and is facilitated by the homologous beta1 subunit. J Virol (2003) 0.93
Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus. J Virol (1991) 0.92
Viruses and cells with mutations affecting viral entry are selected during persistent rotavirus infections of MA104 cells. J Virol (1998) 0.91
A synthetic peptide corresponding to the cleavage region of VP3 from rotavirus SA11 induces neutralizing antibodies. J Virol (1988) 0.90
Further antigenic characterization of porcine rotavirus YM. J Clin Microbiol (1989) 0.89
Discrete domains within the rotavirus VP5* direct peripheral membrane association and membrane permeability. J Virol (2004) 0.89
Analysis of homotypic and heterotypic serum immune responses to rotavirus proteins following primary rotavirus infection by using the radioimmunoprecipitation technique. J Clin Microbiol (1993) 0.88
Characterization of rotavirus electropherotypes excreted by symptomatic and asymptomatic infants. Epidemiol Infect (1991) 0.88
Generation of recombinant rotavirus with an antigenic mosaic of cross-reactive neutralization epitopes on VP4. J Virol (2008) 0.88
Human rotavirus K8 strain represents a new VP4 serotype. J Virol (1993) 0.87
Priming for rotavirus neutralizing antibodies by a VP4 protein-derived synthetic peptide. J Virol (1989) 0.87
Molecular basis of age-dependent gastric inactivation of rhesus rotavirus in the mouse. J Clin Invest (1992) 0.87
Virulence-associated genome mutations of murine rotavirus identified by alternating serial passages in mice and cell cultures. J Virol (2014) 0.86
Characterization of full-length and polymerase chain reaction-derived partial-length Gottfried and OSU gene 4 probes for serotypic differentiation of porcine rotaviruses. J Clin Microbiol (1992) 0.86
Fine mapping of sequential neutralization epitopes on the subunit protein VP8 of human rotavirus. Biochem J (2003) 0.85
Ionic strength- and temperature-induced K(Ca) shifts in the uncoating reaction of rotavirus strains RF and SA11: correlation with membrane permeabilization. J Virol (2002) 0.85
Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus. J Clin Microbiol (1992) 0.84
Heterogeneity of Raft-type membrane microdomains associated with VP4, the rotavirus spike protein, in Caco-2 and MA 104 cells. J Virol (2006) 0.83
Why does the world need another rotavirus vaccine? Ther Clin Risk Manag (2008) 0.83
Isolation and characterization of a novel reassortant between avian Ty-1 and simian RRV rotaviruses. J Virol (1992) 0.82
Cross-linking of rotavirus outer capsid protein VP7 by antibodies or disulfides inhibits viral entry. J Virol (2011) 0.81
Identification and baculovirus expression of the VP4 protein of the human group B rotavirus ADRV. J Virol (1993) 0.80
Development, characterization, and diagnostic applications of monoclonal antibodies against bovine rotavirus. Clin Diagn Lab Immunol (2000) 0.79
A neutralizing monoclonal antibody to bovine rotavirus VP8 neutralizes rotavirus infection without inhibiting virus attachment to MA-104 cells. Can J Vet Res (1998) 0.79
Protection of agammaglobulinemic piglets from porcine rotavirus infection by antibody against simian rotavirus SA-11. J Clin Microbiol (1991) 0.77
Design and Construction of Chimeric VP8-S2 Antigen for Bovine Rotavirus and Bovine Coronavirus. Adv Pharm Bull (2016) 0.75
Human rotavirus strains circulating in Venezuela after vaccine introduction: predominance of G2P[4] and reemergence of G1P[8]. Virol J (2017) 0.75
Characterization of a G1P[8] rotavirus causing an outbreak of gastroenteritis in the Northern Territory, Australia, in the vaccine era. Emerg Microbes Infect (2014) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Mapping adenines, guanines, and pyrimidines in RNA. Nucleic Acids Res (1977) 26.63
Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes. Nucleic Acids Res (1981) 18.27
Nucleotide sequence of cdna coding for Semliki Forest virus membrane glycoproteins. Nature (1980) 8.07
Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis (1984) 7.16
Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology (1981) 6.94
Membrane fusion proteins of enveloped animal viruses. Q Rev Biophys (1983) 6.31
Nucleotide sequence of the 26S mRNA of Sindbis virus and deduced sequence of the encoded virus structural proteins. Proc Natl Acad Sci U S A (1981) 6.08
Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodies. Infect Immun (1983) 5.85
Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol (1983) 5.44
Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology (1983) 5.13
Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol (1981) 4.87
Identification of the two rotavirus genes determining neutralization specificities. J Virol (1986) 4.35
Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus. J Gen Virol (1983) 4.25
Purification and characterization of adenosine triphosphate: ribonucleic acid adenyltransferase from Escherichia coli. Eur J Biochem (1973) 4.06
Antigenic mapping of the surface proteins of rhesus rotavirus. Virology (1986) 3.80
Studies on the in vitro transcription of reovirus RNA catalyzed by reovirus cores. Virology (1969) 3.79
Use of transcription probes for genotyping rotavirus reassortants. Virology (1982) 3.23
Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. J Clin Microbiol (1985) 3.23
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J Virol (1986) 3.17
Viral gastroenteritis. Prog Med Virol (1979) 3.14
Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype. J Virol (1986) 2.97
Primary structure of the cleavage site associated with trypsin enhancement of rotavirus SA11 infectivity. Virology (1985) 2.63
Cross-reactive neutralization epitopes on VP3 of human rotavirus: analysis with monoclonal antibodies and antigenic variants. J Virol (1987) 2.51
Conservation of the fourth gene among rotaviruses recovered from asymptomatic newborn infants and its possible role in attenuation. J Virol (1986) 2.42
Conservation of amino acid sequence of VP8 and cleavage region of 84-kDa outer capsid protein among rotaviruses recovered from asymptomatic neonatal infection. Proc Natl Acad Sci U S A (1986) 2.37
Identification of attenuating mutations on the reovirus type 3 S1 double-stranded RNA segment with a rapid sequencing technique. J Virol (1986) 2.15
Gene protein products of SA11 simian rotavirus genome. J Virol (1982) 2.07
Expression of Semliki Forest virus proteins from cloned complementary DNA. I. The fusion activity of the spike glycoprotein. J Cell Biol (1983) 2.03
A general strategy for cloning double-stranded RNA: nucleotide sequence of the Simian-11 rotavirus gene 8. Nucleic Acids Res (1982) 1.83
Sequence homology between human and animal rotavirus serotype-specific glycoproteins. Nucleic Acids Res (1984) 1.76
Purification of an outer capsid glycoprotein of neonatal calf diarrhea virus and preparation of its antisera. Infect Immun (1983) 1.63
Marked sequence variation between segment 4 genes of human RV-5 and simian SA 11 rotaviruses. Arch Virol (1987) 1.59
Structural homologies between RNA gene segments 10 and 11 from UK bovine, simian SA11, and human Wa rotaviruses. Virology (1985) 1.52
Epitope-specific immune responses to rotavirus vaccination. Gastroenterology (1987) 1.44
Conservation in rotaviruses of the protein region containing the two sites associated with trypsin enhancement of infectivity. Virology (1986) 1.38
Cloning and sequence of UK bovine rotavirus gene segment 7: marked sequence homology with simian rotavirus gene segment 8. Nucleic Acids Res (1983) 1.33
Further investigation on the mode of entry of human rotavirus into cells. Arch Virol (1986) 1.14
In vitro detection of porcine rotavirus-like virus (group B rotavirus) and its antibody. J Clin Microbiol (1985) 1.11
The nucleotide sequence of the 5' and 3' ends of rotavirus SA11 gene 4. Nucleic Acids Res (1987) 1.06
Cell fusion induced by Nelson Bay virus. Virology (1982) 0.89
Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis (1984) 7.16
Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology (1981) 6.94
Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol (1983) 5.44
Human rotavirus type 2: cultivation in vitro. Science (1980) 5.22
Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun (1982) 5.19
Enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1977) 5.17
Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology (1983) 5.13
Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci U S A (1991) 5.02
Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J Clin Microbiol (1983) 4.88
Epidemiology of human rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay. N Engl J Med (1978) 4.73
Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7. J Infect Dis (1987) 4.64
Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med (1982) 4.54
Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine rotavirus. Proc Natl Acad Sci U S A (1981) 4.47
Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus. J Gen Virol (1983) 4.25
Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol (1994) 4.21
Solid-phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies. J Med Virol (1978) 4.06
Structure of hepatitis B Dane particle DNA and nature of the endogenous DNA polymerase reaction. J Virol (1977) 4.02
Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens. Infect Immun (1981) 3.83
Antigenic mapping of the surface proteins of rhesus rotavirus. Virology (1986) 3.80
Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science (1990) 3.70
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A (1999) 3.30
CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity (2000) 3.28
Use of transcription probes for genotyping rotavirus reassortants. Virology (1982) 3.23
Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. J Clin Microbiol (1985) 3.23
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J Virol (1986) 3.17
Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2. Infect Immun (1981) 3.13
Molecular basis of rotavirus virulence: role of gene segment 4. J Virol (1986) 3.08
Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science (1996) 3.07
Rescue and serotypic characterization of noncultivable human rotavirus by gene reassortment. Infect Immun (1982) 2.97
Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype. J Virol (1986) 2.97
Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res (1984) 2.95
Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol (1985) 2.95
Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J Cell Biol (1990) 2.83
Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med (1976) 2.80
Detection of Norwalk virus in stool specimens by reverse transcriptase-polymerase chain reaction and nonradioactive oligoprobes. J Clin Microbiol (1992) 2.77
Infectious rotavirus enters cells by direct cell membrane penetration, not by endocytosis. J Virol (1988) 2.72
Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun (1977) 2.72
Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis (1990) 2.63
Proteins of Norwalk virus. J Virol (1981) 2.59
Viral gastroenteritis. N Engl J Med (1991) 2.58
CCR7 expression and memory T cell diversity in humans. J Immunol (2001) 2.42
The isolation and characterization of a Norwalk virus-specific cDNA. J Clin Invest (1991) 2.42
Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses. Rev Infect Dis (1980) 2.39
Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest (2001) 2.23
Detection and characterization of novel rotavirus strains in the United States. J Clin Microbiol (1998) 2.16
The natural history of the inherited methylmalonic acidemias. N Engl J Med (1983) 2.12
Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11. J Virol (1988) 2.08
Immune response and prevalence of antibody to Norwalk enteritis virus as determined by radioimmunoassay. J Clin Microbiol (1979) 2.06
Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol (1995) 2.06
Role of Norwalk virus in outbreaks of nonbacterial gastroenteritis. J Infect Dis (1979) 2.05
Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J Virol (1994) 2.03
Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. J Virol (1991) 1.99
Characterization of homotypic and heterotypic VP7 neutralization sites of rhesus rotavirus. Virology (1988) 1.98
Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. J Infect Dis (1983) 1.94
Analysis of astrovirus serotype 1 RNA, identification of the viral RNA-dependent RNA polymerase motif, and expression of a viral structural protein. J Virol (1994) 1.94
The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology (1991) 1.92
Cultivation and characterization of three strains of murine rotavirus. J Virol (1986) 1.90
In vitro transcription of two human rotaviruses. J Virol (1982) 1.88
Diversity of rotavirus serotypes in Mexican infants with gastroenteritis. J Clin Microbiol (1990) 1.85
Experimental infection of chimpanzees with the Norwalk agent of epidemic viral gastroenteritis. J Med Virol (1978) 1.84
Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Morocco. Gastroenterology (1979) 1.84
Rotavirus serotypes 6 and 10 predominate in cattle. J Clin Microbiol (1990) 1.81
Norwalk gastrointestinal illness: an outbreak associated with swimming in a recreational lake and secondary person-to-person transmission. Am J Epidemiol (1982) 1.81
The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. J Virol (1989) 1.80
Norwalk virus gastroenteritis following raw oyster consumption. Am J Epidemiol (1982) 1.77
Analyses of homologous rotavirus infection in the mouse model. Virology (1995) 1.75
Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers. Infect Immun (1973) 1.72
Prevalence of antibody to the Norwalk agent by a newly developed immune adherence hemagglutination assay. J Med Virol (1978) 1.72
Molecular determinant of rotavirus neutralization and protection. Adv Virus Res (1989) 1.65
Culture of an organophosphorus-resistant strain of Boophilus microplus (Can.) and an assessment of its resistance spectrum. Bull Entomol Res (1966) 1.64
Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence. J Virol (1993) 1.64
Immunity to homologous rotavirus infection in adult mice. Trends Microbiol (2000) 1.62
Both surface proteins (VP4 and VP7) of an asymptomatic neonatal rotavirus strain (I321) have high levels of sequence identity with the homologous proteins of a serotype 10 bovine rotavirus. Virology (1993) 1.58
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. J Clin Microbiol (1989) 1.58
Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo. J Virol (1996) 1.56
Prevalence of antibody to the Norwalk virus in various countries. Infect Immun (1979) 1.54
Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis (2001) 1.54
Rotavirus VP7 neutralization epitopes of serotype 3 strains. Virology (1989) 1.54
Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes. J Virol (1990) 1.51
Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology (1994) 1.51
Expression of mucosal homing receptor alpha4beta7 by circulating CD4+ cells with memory for intestinal rotavirus. J Clin Invest (1997) 1.51
Identification and partial characterization of a rhesus rotavirus binding glycoprotein on murine enterocytes. Virology (1991) 1.50
Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49